John Collison

speaker

6,048 appearances 22 recordings 1 series first heard Jun 2025 last heard 5 Feb

John Collison’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months

Recordings per month over the last 12 months — 10 in all, peaking in Oct 2025 with 5.

Appearances

newest first · ▶ plays the moment

Cheeky Pint · Dave Ricks, CEO of Eli Lilly, on GLP-1s and the business of pharma · 11 Nov 2025 podcast

Uh and then it was noticed during the clinical trials that people were losing weight.

Yes.

Uh and so now I think the big societal discussion, like Pat and I were talking about at the information is a Silicon Valley Tech publication, and they're on a survey about GLP ones, and half of readers of the information are on GLP ones.

Exactly.

As you can tell, it's not a normal region.

Could be potentially adopters.

So there's this big weight loss discussion, and you know that's the Ozempic is obviously a different brand name for a different drug, but um people are very familiar with this.

But now it seems like we are starting to figure out there are all these.

Other potential benefits of GLPs that do not seem to be fully explained by the weight loss.

And so there's the cardiovascular benefits, there's you know potential Alzheimer's links, there's fertility, there are all these things that aren't just

you lost weight.

What do you think is going on there?

Well I was just gonna so you're just saying this um

Being oversated causes inflammation, which then causes all these ostensibly unrelated downstream

that.

It's interesting that all the growth in Staten has happened even while it was branded.

You know, you'd expect a big bump after it went generic.

Well

And your direct stuff.

I mean we've talked about it once or twice.

Showing 1021–1040 of 6,048 · page 52 of 303